4-APB

Pharmaceutical compound From Wikipedia, the free encyclopedia

4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family.[3][4][5][2][1] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA).[1][2] The drug was first detected, in Europe, by 2011.[3]

Other names4-(2-Aminopropyl)benzofuran; 4-APB
CAS Number
Quick facts Clinical data, Other names ...
4-APB
Clinical data
Other names4-(2-Aminopropyl)benzofuran; 4-APB
Drug classSerotonin–norepinephrine–dopamine releasing agent[1][2]
Identifiers
  • 1-(1-benzofuran-4-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H13NO
Molar mass175.231 g·mol−1
3D model (JSmol)
  • CC(CC1=C2C=COC2=CC=C1)N
  • InChI=1S/C11H13NO/c1-8(12)7-9-3-2-4-11-10(9)5-6-13-11/h2-6,8H,7,12H2,1H3
  • Key:XROLBZOMVNMIFN-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI